Aurobindo Pharma Ltd has received final USFDA approval to manufacture and market Guaifenesin extended-release tablets in USA.
The drug Guaifenesin extended-release tablets are the AB rated generic equivalent of RB Health (US) LLC’s Mucinex tablets. Guaifenesin extended-release tablets helps to loosen phlegm (mucus), and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.
The approved product has an estimated market size of $ 301 million for the twelve months ending July 2019.
Company Profile : Aurobindo Pharma Ltd
Leave a Reply